How viruses cause cancer
- General virology
Some viruses push infected cells towards cancer. Knowing which ones matters because vaccines and treatment of the infection prevent those cancers.
What it is
A handful of human viruses cause a substantial share of cancers worldwide: HPV, hepatitis B and C, EBV, HHV-8, HTLV-1 and Merkel cell polyomavirus. They act by carrying genes that switch off tumour suppressors or drive growth signals, by inserting into the genome, or by causing years of inflammation and tissue repair. Infection is necessary but not enough: cancer appears in a minority of those infected, after extra genetic changes and often immune failure.
Key facts
- Acutely transforming animal retroviruses carry captured cell oncogenes (v-onc, e.g. v-src); slow-transforming ones activate a host oncogene by inserting next to it
- DNA tumour viruses force resting cells into S phase to copy their own DNA; when the cell cycle brakes p53 and Rb are disabled, damaged cells keep dividing
- HPV types 16 and 18 cause about three quarters of cervical cancers; progression from infection to cancer usually takes 15 to 20 years, faster with untreated HIV
- HIV does not cause cancer directly but greatly raises the risk of virus-driven cancers (Kaposi sarcoma, lymphomas, cervical and anal cancer)
- Infection with hepatitis B in infancy usually becomes chronic, which is why the birth dose of vaccine prevents liver cancer decades later
Function
- Proving causation: consistent epidemiological association that precedes the cancer
- Viral genome present in the tumour cells, often clonally integrated, and viral oncogenes expressed
- Viral genes transform cells in culture or cause tumours in animals
- Preventing the infection prevents the cancer: hepatitis B vaccination lowered liver cancer, HPV vaccination lowers cervical precancer and cancer
Step by step
- High-risk HPV infects the basal cells of the cervical epithelium
- Most infections are cleared; a minority persist for years
- Viral DNA integrates into a host chromosome and E6 and E7 are made in larger amounts
- E6 sends p53 for destruction and E7 inactivates Rb, so the cell-cycle brakes fail
- Damaged cells keep dividing and collect mutations: precancer (cervical intraepithelial neoplasia)
- Over 15 to 20 years, if not found by screening and treated, some lesions become invasive cancer
Human oncogenic viruses
| Virus | Genome | Main cancers | Key mechanism |
|---|---|---|---|
| High-risk HPV (16, 18 and others) | DNA | Cervical, anal, oropharyngeal, vulvar, vaginal and penile cancer | E6 degrades p53; E7 inactivates Rb; integration raises E6 and E7 |
| Hepatitis B virus | DNA (reverse transcribing) | Hepatocellular carcinoma | Chronic inflammation and regeneration, DNA integration, HBx protein |
| Hepatitis C virus | RNA | Hepatocellular carcinoma, some B-cell lymphomas | Chronic inflammation and cirrhosis; no integration |
| Epstein-Barr virus | DNA (herpesvirus) | Burkitt, Hodgkin and post-transplant lymphoma, nasopharyngeal carcinoma | Latency proteins (LMP1 mimics an activated CD40 receptor) drive B-cell growth |
| HHV-8 (Kaposi sarcoma herpesvirus) | DNA (herpesvirus) | Kaposi sarcoma, primary effusion lymphoma, multicentric Castleman disease | LANA blocks p53 and Rb; viral cytokine and receptor mimics |
| HTLV-1 | RNA (retrovirus) | Adult T-cell leukaemia/lymphoma | Tax protein activates host growth genes |
| Merkel cell polyomavirus | DNA | Merkel cell carcinoma | Clonal integration with a truncated large T antigen that binds Rb |
Clinical notes
- Prevention: HPV and hepatitis B vaccines (both in Colombia's PAI schedule), cervical screening with HPV testing, treating chronic hepatitis B and C, HIV treatment
- Burkitt lymphoma carries an 8;14 translocation that moves MYC next to an immunoglobulin gene; the endemic African form is almost always EBV positive
- Primary CNS lymphoma in people with advanced HIV is typically EBV positive
Common traps
- Every high-risk HPV infection leads to cancer: most are cleared; cancer needs persistent infection, extra mutations and usually 15 to 20 years.
- Hepatitis C causes liver cancer by inserting into the genome: it is an RNA virus that never integrates; cancer follows decades of inflammation and cirrhosis.
- HIV itself is an oncogenic virus: it does not transform cells directly; it raises the risk of cancers driven by other viruses through immune failure.
- Kaposi sarcoma is caused by HIV: it is caused by HHV-8, which HIV-related immunosuppression lets grow.
- Finding a virus in a tumour proves it caused the tumour: causation also needs infection before the cancer, viral genes that transform cells and fewer cancers when infection is prevented.
Test yourself
Think of the answer, then tap the question to see it.
Why does the birth dose of hepatitis B vaccine help prevent liver cancer decades later?
Infection in infancy usually becomes chronic, and decades of chronic hepatitis B lead to hepatocellular carcinoma. Preventing infection at birth removes that path.
A cervical cancer specimen shows high-risk HPV DNA integrated into the tumour cell genome. Why does integration matter?
Integration raises production of E6 and E7, which disable p53 and Rb, so the cell loses two main brakes on division.
A man with advanced HIV develops purple skin plaques. Which virus causes them, and what role does HIV play?
HHV-8 causes Kaposi sarcoma. HIV does not transform the cells; its immunosuppression lets HHV-8-infected cells grow.
A child in equatorial Africa has a fast-growing lymphoma with an 8;14 translocation. Which virus is almost always present, and what does the translocation do?
Epstein-Barr virus (endemic Burkitt lymphoma). The translocation moves MYC next to an immunoglobulin gene, driving constant growth.
Why is a liver cancer caused by hepatitis C almost always preceded by cirrhosis?
Hepatitis C does not integrate or carry oncogenes; it causes cancer only through decades of inflammation, cell death and regeneration, which also produce cirrhosis.
Connections
Microorganisms8
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Infectious Agents (National Cancer Institute (NCI), 2025); Cervical cancer (World Health Organization (WHO), 2024); Clinical Overview of Hepatitis B (CDC, 2025); Human T-lymphotropic virus-1 (World Health Organization (WHO), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
